Cognition and fatigue in patients with relapsing multiple sclerosis treated by subcutaneous interferon β-1a: an observational study SKORE (Q33589940)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450892%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

title

Cognition and fatigue in patients with relapsing multiple sclerosis treated by subcutaneous interferon β-1a: an observational study SKORE (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450892%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450892%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Aleš Tvaroh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450892%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

publication date

21 October 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450892%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic advances in neurological disorders

19 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450892%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450892%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450892%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

18-32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450892%20AND%20SRC:MED&resulttype=core&format=json

Sleep and Cognitive Function in Multiple Sclerosis

19 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Factors influencing long-term outcomes in relapsing-remitting multiple sclerosis: PRISMS-15.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Cognitive Reserve as a Useful Concept for Early Intervention Research in Multiple Sclerosis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Searching for the neural basis of reserve against memory decline: intellectual enrichment linked to larger hippocampal volume in multiple sclerosis.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Small non-coding RNA signature in multiple sclerosis patients after treatment with interferon-β.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Fatigue is associated with poor sleep in people with multiple sclerosis and cognitive impairment

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

The dopaminergic system in autoimmune diseases

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Higher education moderates the effect of T2 lesion load and third ventricle width on cognition in multiple sclerosis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Apathy/depression, but not subjective fatigue, is related with cognitive dysfunction in patients with multiple sclerosis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Neural correlates of cognitive fatigue: cortico-striatal circuitry and effort-reward imbalance

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Grey matter damage in multiple sclerosis: a pathology perspective

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks?

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Neurobiological studies of fatigue

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Risk factors for and management of cognitive dysfunction in multiple sclerosis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Inverted-U-shaped dopamine actions on human working memory and cognitive control

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Cognition in multiple sclerosis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

The contribution of MRI in assessing cognitive impairment in multiple sclerosis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Multiple sclerosis-associated fatigue

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Cognitive deficits in multiple sclerosis: a systematic review

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

The multiple sclerosis functional composite: a clinically meaningful measure of disability

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

PRISMS: the story of a pivotal clinical trial series in multiple sclerosis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

In vivo MR imaging of hippocampal lesions in multiple sclerosis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

What do we know about the mechanism of action of disease-modifying treatments in MS?

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Intracranial capacity and brain volumes are associated with cognition in healthy elderly men.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosis.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

The Fatigue Descriptive Scale (FDS): a useful tool to evaluate fatigue in multiple sclerosis.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

The impact of fatigue on patients with multiple sclerosis.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Neuropsychology of multiple sclerosis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Paced auditory serial-addition task: a measure of recovery from concussion

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Fatigue and processing speed are related in multiple sclerosis

14 July 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285616671882

Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285616671882

Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285616671882

Interferon-gamma and interferon-beta affect endogenous catecholamines in human peripheral blood mononuclear cells: implications for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285616671882

Memory decline evolves independently of disease activity in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285616671882

Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285616671882

Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285616671882

Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285616671882

A prospective study of patterns of fatigue in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285616671882

Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285616671882

Validity of performance scales for disability assessment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285616671882

Fatigue and cognition in patients with relapsing multiple sclerosis treated with interferon β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285616671882

Is there a differential impact of fatigue and physical disability on quality of life in multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285616671882

Cognitive reserve moderates the impact of subcortical gray matter atrophy on neuropsychological status in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285616671882

Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285616671882

Cognitive reserve and patient-reported outcomes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285616671882

Understanding multiple sclerosis fatigue: a synthesis of biological and psychological factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285616671882

Therapy with interferon-beta modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285616671882

Frequency of cognitive impairment dramatically increases during the first 5 years of multiple sclerosis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Early treatment of multiple sclerosis with Rebif (recombinant human interferon beta): design of the study.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400153

Cognitive impairment in multiple sclerosis

31 October 2018

1 reference

12 December 2020

Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study

1 reference

12 December 2020

Dopaminergic Modulation of CD4+CD25high Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-ß Therapy

1 reference

12 December 2020

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

1 reference

12 December 2020

Effects of immunomodulatory treatment with subcutaneous interferon beta-1a oncognitive decline in mildly disabled patients with relapsing—remitting multiple sclerosis

1 reference

12 December 2020

Fatigue in multiple sclerosis and its relationship to depression and neurologic disability

1 reference

12 December 2020

Interferons in relapsing remitting multiple sclerosis

1 reference

12 December 2020

1 reference

12 December 2020

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus

1 reference

12 December 2020

Staying on the job: The relationship between work performance and cognition in individuals diagnosed with multiple sclerosis

1 reference

12 December 2020

Identifiers

DOI

10.1177/1756285616671882

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450892%20AND%20SRC:MED&resulttype=core&format=json

release_ffe6jweefbgtbem5rfq6sahoty

19 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ffe6jweefbgtbem5rfq6sahoty

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450892%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

PubMed publication ID

28450892

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450892%20AND%20SRC:MED&resulttype=core&format=json